Rein Therapeutics, Inc.
41 SEC EDGAR filings indexed (CIK 0001420565) across 11 form types.
Filing profile
Rein Therapeutics, Inc. (RNTX) has 41 SEC filings indexed on SecFilingDex, across 11 form types filed over roughly 2 years, from August 14, 2024 to August 14, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).
Its most frequent disclosure is the 8-K (Material event) with 8 filings — Current report announcing a material event, such as an acquisition, executive change, or earnings release. 25 of these filings were disclosed in the twelve months to August 14, 2026. 2 of the 41 are amendments (a corrected or updated version of an earlier filing).
Disclosure mix
- 88-KMaterial event · event-driven
- 8Form 4Insider transaction · within 2 business days of transaction
- 710-QQuarterly report · quarterly
- 4DEFA14ASEC filing
- 4424B5Prospectus supplement · event-driven
- 2DEF 14AProxy statement · annual (pre-meeting)
- 2S-1IPO registration · event-driven (pre-ipo)
- 210-K/AAnnual report · annual
- 210-KAnnual report · annual
- 1PRE 14ASEC filing
- 1Form 3Initial insider ownership · within 10 days of becoming an insider
Profile derived from 41 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.
All filings
- 10-QQuarterly report · period of report Jun 30, 2026Filed · 0001193125-26-350270
- 8-KMaterial event · period of report Jul 20, 2026Filed · 0001193125-26-310315
- DEF 14AProxy statement · period of report Jul 20, 2026Filed · 0001193125-26-260809
- DEFA14ASEC filingFiled · 0001193125-26-260812
- PRE 14ASEC filing · period of report Jul 20, 2026Filed · 0001193125-26-245389
- Form 4Insider transaction · period of report May 21, 2026Filed · 0001193125-26-245832
- 10-QQuarterly report · period of report Mar 31, 2026Filed · 0001193125-26-225352
- Form 4Insider transaction · period of report Apr 30, 2026Filed · 0001193125-26-220718
- 424B5Prospectus supplementFiled · 0001193125-26-202429
- 8-KMaterial event · period of report Apr 30, 2026Filed · 0001193125-26-204006
- S-1IPO registrationFiled · 0001193125-26-187803
- 10-K/AAnnual report · period of report Dec 31, 2025Filed · 0001193125-26-178787
- 10-KAnnual report · period of report Dec 31, 2025Filed · 0001193125-26-126385
- 8-KMaterial event · period of report Feb 24, 2026Filed · 0001193125-26-084012
- 8-KMaterial event · period of report Feb 16, 2026Filed · 0001193125-26-059545
- 8-KMaterial event · period of report Jan 15, 2026Filed · 0001193125-26-015524
- 8-KMaterial event · period of report Dec 11, 2025Filed · 0001193125-25-316225
- Form 4Insider transaction · period of report Nov 14, 2025Filed · 0000921895-25-003156
- 10-QQuarterly report · period of report Sep 30, 2025Filed · 0001193125-25-281622
- 8-KMaterial event · period of report Nov 3, 2025Filed · 0001193125-25-261706
- Form 4Insider transaction · period of report Oct 24, 2025Filed · 0000921895-25-002819
- 8-KMaterial event · period of report Oct 23, 2025Filed · 0001193125-25-250175
- Form 3Initial insider ownership · period of report Sep 24, 2025Filed · 0000921895-25-002688
- S-1IPO registrationFiled · 0001193125-25-195041
- 10-QQuarterly report · period of report Jun 30, 2025Filed · 0000950170-25-108836
- 424B5Prospectus supplementFiled · 0001193125-25-168822
- 424B5Prospectus supplementFiled · 0001193125-25-168827
- Form 4Insider transaction · period of report Jul 23, 2025Filed · 0000950170-25-098041
- Form 4Insider transaction · period of report Jul 23, 2025Filed · 0000950170-25-098043
- Form 4Insider transaction · period of report Jul 23, 2025Filed · 0000950170-25-098044
- Form 4Insider transaction · period of report Jul 23, 2025Filed · 0000950170-25-098046
- DEFA14ASEC filingFiled · 0001193125-25-158200
- DEFA14ASEC filingFiled · 0001193125-25-145714
- 10-QQuarterly report · period of report Mar 31, 2025Filed · 0000950170-25-072607
- 424B5Prospectus supplementFiled · 0001193125-25-120767
- DEF 14AProxy statement · period of report Jun 24, 2025Filed · 0001193125-25-117820
- DEFA14ASEC filingFiled · 0001193125-25-117825
- 10-K/AAnnual report · period of report Dec 31, 2024Filed · 0001193125-25-107666
- 10-KAnnual report · period of report Dec 31, 2024Filed · 0000950170-25-051566
- 10-QQuarterly report · period of report Sep 30, 2024Filed · 0000950170-24-127019
- 10-QQuarterly report · period of report Jun 30, 2024Filed · 0000950170-24-097199
Authoritative source
SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.
Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.